These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28089501)

  • 1. Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review.
    Maese J; Díaz Del Campo P; Seoane-Mato D; Guerra M; Cañete JD
    Reumatol Clin (Engl Ed); 2018; 14(2):81-89. PubMed ID: 28089501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
    Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
    Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is obesity in psoriatic arthritis associated with a poorer therapeutic response and more adverse effects of treatment with an anchor drug?
    Galíndez E; Carmona L
    Reumatol Clin; 2016; 12(6):307-312. PubMed ID: 26830438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
    Lubrano E; Scarpa R
    Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review.
    Calvo Alén J; Pérez T; Romero Yuste S; Ferraz-Amaro I; Alegre Sancho JJ; Pinto Tasende JA; Maceiras Pan F; Quevedo JC; Hernández-Hernández MV; Hidalgo Calleja C; San Martín Álvarez A; Sánchez MIT; Sanmartí R
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):324-332. PubMed ID: 30241955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
    Mulder MLM; Vriezekolk JE; den Broeder N; Mahler EAM; Helliwell PS; van den Hoogen FHJ; den Broeder AA; Wenink MH
    Trials; 2020 Feb; 21(1):155. PubMed ID: 32041657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.
    Ash Z; Gaujoux-Viala C; Gossec L; Hensor EM; FitzGerald O; Winthrop K; van der Heijde D; Emery P; Smolen JS; Marzo-Ortega H
    Ann Rheum Dis; 2012 Mar; 71(3):319-26. PubMed ID: 21803753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review.
    Hsieh TS; Tsai TF
    Immunotherapy; 2024 Feb; 16(2):115-130. PubMed ID: 38112064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.
    Palazzi C; D'Angelo S; Leccese P; Padula A; Olivieri I
    Expert Opin Drug Saf; 2014 Feb; 13(2):191-6. PubMed ID: 24219428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors.
    Chan J; Gladman D
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):415-426. PubMed ID: 31171312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
    Nash P; Clegg DO
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.
    Steiman AJ; Pope JE; Thiessen-Philbrook H; Li L; Barnabe C; Kalache F; Kung T; Bessette L; Flanagan C; Haraoui B; Hochman J; Leclercq S; Mosher D; Thorne C; Bykerk V
    Rheumatol Int; 2013 May; 33(5):1105-20. PubMed ID: 23292213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
    Kerschbaumer A; Smolen JS; Dougados M; de Wit M; Primdahl J; McInnes I; van der Heijde D; Baraliakos X; Falzon L; Gossec L
    Ann Rheum Dis; 2020 Jun; 79(6):778-786. PubMed ID: 32381564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
    Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
    Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
    Soriano ER
    J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the use of methotrexate in psoriatic arthritis.
    Cañete JD; Ariza-Ariza R; Bustabad S; Delgado C; Fernández-Carballido C; García Llorente JF; Loza E; Montilla C; Naranjo A; Pinto JA; Queiro R; Ramírez J; Tornero-Molina J
    Reumatol Clin (Engl Ed); 2018; 14(4):183-190. PubMed ID: 29050840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis.
    Garcia-Leal M; Reyes-Soto MA; Hernandez-Galarza I; Alvarez-Villalobos NA; Galarza-Delgado DA; Flores-Alvarado DE
    Clin Rheumatol; 2021 Sep; 40(9):3499-3510. PubMed ID: 33576924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enthesitis in psoriatic arthritis.
    Sakkas LI; Alexiou I; Simopoulou T; Vlychou M
    Semin Arthritis Rheum; 2013 Dec; 43(3):325-34. PubMed ID: 23731532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apremilast for the treatment of psoriatic arthritis.
    Souto A; Gómez-Reino JJ
    Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.